Our Strategic Priorities

Our supply chain strategy supports business growth, customer success, and long-term sustainability.
Reliable Supply
Ensuring uninterrupted product availability across global markets.
Quality & Compliance
Meeting the highest standards of regulatory compliance and product quality.
Supplier Collaboration
Building strong partnerships that drive innovation and continuous improvement.
Digital Procurement
Leveraging technology and data to enhance efficiency and transparency.
Sustainable Value Chains
Reducing environmental impact and advancing responsible sourcing practices.
Risk & Resilience
Strengthening supply continuity through proactive risk management and business continuity planning.
What We Expect From Our Suppliers
Quality & Compliance
Maintain robust quality systems, regulatory compliance, and audit readiness while proactively communicating material changes.
Supply Reliability
Deliver products and services consistently, on time, and in full, while maintaining transparent communication regarding potential disruptions.
Regulatory Excellence
Provide accurate documentation, maintain applicable certifications (cGxP, ICH, ISO 9001/14001/45001, GMP, FDA, etc), and support regulatory inspections and audits.
Responsible Sourcing
Operate ethically, transparently, and sustainably, uphold human rights, prevent forced or child labour, and comply with our Supplier Code of Conduct and Sustainable Procurement Policy.
Risk Resilience
Maintain business continuity plans, identify critical risks, and collaborate on supply chain resilience initiatives.
Ethics & Integrity
Demonstrate the highest standards of ethical conduct, Uphold zero tolerance for bribery and corruption, data privacy protection, and transparent reporting.

Visit Piramal Pharma Solutions Supply Chain page for additional requirements and category-specific guidance on our CDMO business.
Our Sustainability Commitments
Sustainability is embedded across our supply chain strategy.
42% reduction in Scope 1 and Scope 2 emissions by FY2030 (FY2022 baseline)
25% reduction in Scope 3 emissions by FY2030 (FY2022 baseline)
Science Based Targets initiative (SBTi)-validated emission reduction targets
Active Full Member of the Pharmaceutical Supply Chain Initiative (PSCI)
Reporting aligned with EcoVadis, PSCI, BRSR, CDP, GRI, S&P Global, UNGC, M2030
Compliance with Canada's Bill S-211 on forced and child labour in supply chains
Partnering For Impact
Measure and disclose greenhouse gas emissions
Adopt science-based climate targets
Strengthen ESG governance and reporting
Embed sustainability practices throughout their operations
Supplier Development & Collaboration
We view suppliers as strategic partners in delivering quality, innovation, and sustainable growth.

Our supplier development programs include:
- Quality, regulatory, and ESG capability-building workshops
- Supplier performance reviews and improvement plans
- Innovation partnerships for new materials and sustainable solutions
- Digital collaboration through sourcing and supplier management platforms
- Partner with suppliers on LCA and PCF studies to identify carbon reduction opportunities.
We value partners who share our commitment to continuous improvement, transparency, and long-term collaboration.
Supplier Sustainability Progress
Suppliers governed by Supplier Code of Conduct
Supplier assessments completed, including >50% of critical suppliers
Participants trained on Sustainability across 120+ global suppliers
Become A Piramal Pharma Supplier
We welcome partnerships across a broad range of categories
Active pharmaceutical ingredients (APIs), intermediates, and excipients
Contract manufacturing and analytical services
Specialty raw materials and nutraceutical ingredients
LCA & PCF-Enabled Material Supplier
Sustainable packaging innovations across primary and secondary formats
Capital equipment, MRO, and indirect procurement
Interested In Partnering With Us?
Register Your Interest
Supplier Expression of InterestContact Us
Submit Your QueryFAQ
Submit your company profile through our Supplier Expression of Interest portal. Shortlisted suppliers are invited for qualification and onboarding.
We source for all three businesses PPS (CDMO), PCC (critical care), and PCH (consumer healthcare) under one unified group governance framework.
Yes. We recognise EcoVadis, PSCI, Sedex, CDP, and DJSI assessments to reduce audit duplication for our suppliers.
Suppliers are expected to disclose ESG metrics, report emissions data, and progressively align with science-based targets. Detailed expectations are set out in our Supplier Sustainability Guidelines.
Audits are conducted based on supplier risk profiles typically annually to once every three years - through self-assessments, on-site audits, and PSCI assessments.
Fill out this form for any questions – Contact Us
Explore Supply Chain by Business
External Standards & References
Piramal Pharma aligns its supply chain practices with global benchmarks including The GHG Protocol, Science-Based Targets initiative (SBTi), UN Sustainable Development Goals (SDGs), PSCI Principles, and Applicable global regulatory authority guidelines.


